Stephanie Becker: ESOC 2026 Highlights Are Now Live in The Lancet Regional Health – Europe
Stephanie Becker, Senior Editor at The Lancet Regional Health – Europe, shared on LinkedIn:
”Exciting advances in stroke research were front and centre at ESOC 2026 in Maastricht, where more than 4000 delegates from 96 countries gathered to discuss the future of stroke prevention, intervention, and recovery.
Our conference highlights are now live in The Lancet Regional Health – Europe.
I was delighted to attend this conference held by the European Stroke Organisation, meeting enthusiastic and driven researchers and hearing about the latest research in the field that could help shape the next generation of stroke care.
Some standout findings included:
- The HOPE trial, showing that personalised blood pressure targets after thrombectomy may significantly improve functional recovery after acute ischaemic stroke.
- New OCEANIC-STROKE analyses suggesting that asundexian not only reduces recurrent stroke risk, but may also lessen stroke severity and disability.
- The DISTALS trial, demonstrating promising results for a novel low-profile stent-retriever designed specifically for distal vessel occlusions.
- ATILA trial findings showing that low-dose tirofiban reduced acute in-stent thrombosis by more than half following thrombectomy and carotid stenting.
- The ATLAS meta-analysis, providing compelling evidence that patients with large-core ischaemic stroke can still benefit from endovascular thrombectomy — challenging long-standing assumptions in the field.
What stood out most at this year’s meeting was the momentum across stroke research: from refining thrombectomy strategies to improving secondary prevention and expanding treatment eligibility for patients previously thought unlikely to benefit.
A fascinating and energising few days for everyone working in cerebrovascular medicine.
Read my full conference highlights.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series